IX Biopharma Issues 1.7 Million New Shares Under Performance Plan

MT NewswiresFeb 23 19:11 ET

IX Biopharma Proposes Appointment of BDO LLP as New Auditors

TipRanksFeb 20 06:42 ET

IX Biopharma Loss Narrows in H2 2024

MT NewswiresFeb 10 00:30 ET

Financial Statements and Related Announcement-Half Yearly Results

SGXFeb 7 04:30 ET · Announcements

IX Biopharma Discloses Result of IXB 401 Preclinical Study

MT NewswiresNov 19, 2024 18:45 ET

IX Biopharma's IXB 401: A Breakthrough in Drug Delivery

TipRanksNov 19, 2024 05:14 ET

IX Biopharma Unveils Growth Plans at AGM

TipRanksNov 15, 2024 05:16 ET

IX Biopharma Ltd. Holds Key Shareholder Meeting

TipRanksNov 15, 2024 05:16 ET

IX Biopharma Restructures Board Committees for Efficiency

TipRanksOct 17, 2024 07:12 ET

IX Biopharma Welcomes Aging Expert to Advisory Board

TipRanksOct 14, 2024 06:13 ET

IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions

MT NewswiresSep 30, 2024 22:52 ET

Financial Statements and Related Announcement-Auditor's Comments of Accounts

SGXSep 30, 2024 10:52 ET · Announcements

IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401

MT NewswiresSep 16, 2024 22:41 ET

New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells

PR NewswireSep 1, 2024 21:00 ET

IX Biopharma's New Wafer Revolutionizes NAD+ Supplementation

TipRanksSep 1, 2024 20:17 ET

IX Biopharma Widens Net Loss by 12% in FY2024

Singapore Business ReviewAug 27, 2024 04:51 ET

IX Biopharma's Net Attributable Loss Widens in Fiscal H2

MT NewswiresAug 26, 2024 00:46 ET

IX Biopharma Full Year 2024 Earnings: S$0.014 Loss per Share (Vs S$0.013 Loss in FY 2023)

Yahoo FinanceAug 24, 2024 21:57 ET

Financial Statements and Related Announcement-Full Yearly Results

SGXAug 23, 2024 06:02 ET · Announcements

IX Biopharma's CBD Wafer Shows Potential in Improving Symptoms for Kidney Failure Patients; Shares Up 4%

MT NewswiresAug 12, 2024 23:15 ET